{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T09:35:18Z","timestamp":1783244118590,"version":"3.54.6"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Metastatic risk stratification is critical for uveal melanoma (UM) management, as approximately up to half of patients develop metastatic disease. Current prognostication for patients undergoing eye-preserving therapies relies on tumor staging and molecular analysis of tumor tissue obtained through potentially invasive biopsy, which can be challenging. While liquid biopsy using cell-free DNA (cfDNA) has emerged as a less invasive alternative for other cancers, studies have shown limited utility of blood-derived cfDNA in UM due to low tumor DNA fractions. This study investigates the potential of aqueous humor (AH) and vitreous body (VB) aspirates as alternative sources of tumor DNA for molecular prognostication in UM patients at the time of diagnosis.\u00a0In this prospective study, AH and\/or VB samples were collected from 96 consecutive UM patients undergoing enucleation, transretinal endoresection or transretinal biopsy. DNA was extracted from the ocular fluids and analyzed for the presence of tumor-derived DNA using deep amplicon sequencing targeting mutations in <jats:italic>GNAQ<\/jats:italic> and <jats:italic>GNA11<\/jats:italic>. This approach achieved an average read depth of 120,000, enabling highly sensitive detection of tumor-specific variants. Tumor DNA was detected in at least one ocular fluid (AH or VB) in 43 of 88 evaluable patients (49%), with variant allele fractions (VAFs) ranging from 0.3 to 50%. Of these positive cases, tumor DNA was identified in VB only in 22 patients, AH only in 5 patients, and both fluids in 16 patients. Importantly, tumor DNA in AH was almost exclusively observed in patients with monosomy 3\u00a0UM. No significant correlation was found between the presence of tumor DNA in either ocular fluid and primary tumor size or location.\u00a0Liquid biopsy of AH and VB offers a promising, minimally invasive strategy for obtaining tumor DNA in nearly half of UM patients at diagnosis. The strong association between detectable tumor DNA in AH and monosomy 3 status warrants further investigation and may offer valuable insights into UM biology and dissemination mechanisms. This approach may improve risk stratification and inform personalized treatment strategies for patients with UM.<\/jats:p>","DOI":"10.1038\/s41598-025-03915-7","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T09:14:26Z","timestamp":1748942066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Presence of tumor DNA in aqueous humor is correlated with high risk uveal melanoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Nicole","family":"Barwinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mael","family":"Lever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Rating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Jabbarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miltiadis","family":"Fiorentzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos E.","family":"Bechrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar R.","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zeschnigk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia H. D.","family":"Le Guin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"12","key":"3915_CR1","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili, G. et al. Incidence of uveal melanoma in Europe. Ophthalmology 114 (12), 2309\u20132315 (2007).","journal-title":"Ophthalmology"},{"issue":"11","key":"3915_CR2","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala, E., Makitie, T. & Kivela, T. Very long-term prognosis of patients with malignant uveal melanoma. Invest. Ophthalmol. Vis. Sci. 44 (11), 4651\u20134659 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"3915_CR3","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/bjo.2005.069823","volume":"89","author":"PT Finger","year":"2005","unstructured":"Finger, P. T., Kurli, M., Reddy, S., Tena, L. B. & Pavlick, A. C. Whole body PET\/CT for initial staging of choroidal melanoma. Br. J. Ophthalmol. 89 (10), 1270\u20131274 (2005).","journal-title":"Br. J. Ophthalmol."},{"issue":"9010","key":"3915_CR4","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","volume":"347","author":"G Prescher","year":"1996","unstructured":"Prescher, G. et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347 (9010), 1222\u20131225 (1996).","journal-title":"Lancet"},{"issue":"1","key":"3915_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0165-4608(00)00266-1","volume":"122","author":"F Tschentscher","year":"2000","unstructured":"Tschentscher, F., Prescher, G., Zeschnigk, M., Horsthemke, B. & Lohmann, D. R. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet. Cytogenet. 122 (1), 13\u201317 (2000).","journal-title":"Cancer Genet. Cytogenet."},{"issue":"8","key":"3915_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ng.2674","volume":"45","author":"M Martin","year":"2013","unstructured":"Martin, M. et al. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat. Genet. 45 (8), 933\u2013936 (2013).","journal-title":"Nat. Genet."},{"issue":"28","key":"3915_CR7","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1200\/JCO.24.00447","volume":"42","author":"JW Harbour","year":"2024","unstructured":"Harbour, J. W. et al. 15-Gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of collaborative ocular oncology group study 2 (COOG2.1). J. Clin. Oncol. 42 (28), 3319\u20133329 (2024).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"3915_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10897-009-9223-2","volume":"18","author":"TM Beran","year":"2009","unstructured":"Beran, T. M., McCannel, T. A., Stanton, A. L., Straatsma, B. R. & Burgess, B. L. Reactions to and desire for prognostic testing in choroidal melanoma patients. J. Genet. Couns. 18 (3), 265\u2013274 (2009).","journal-title":"J. Genet. Couns."},{"issue":"4","key":"3915_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1369-7625.2010.00639.x","volume":"14","author":"SA Cook","year":"2011","unstructured":"Cook, S. A., Damato, B., Marshall, E. & Salmon, P. Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma. Health Expect. 14 (4), 383\u2013396 (2011).","journal-title":"Health Expect."},{"issue":"7","key":"3915_CR10","first-page":"106","volume":"115","author":"N Bornfeld","year":"2018","unstructured":"Bornfeld, N. et al. The interdisciplinary diagnosis and treatment of intraocular tumors. Dtsch. Arztebl Int. 115 (7), 106\u2013111 (2018).","journal-title":"Dtsch. Arztebl Int."},{"key":"3915_CR11","first-page":"8","volume":"11","author":"L Frizziero","year":"2019","unstructured":"Frizziero, L. et al. Uveal Melanoma Biopsy: Rev. Cancers (Basel) ;11(8). (2019).","journal-title":"Uveal Melanoma Biopsy: Rev. Cancers (Basel)"},{"issue":"7229","key":"3915_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CD Van Raamsdonk","year":"2009","unstructured":"Van Raamsdonk, C. D. et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue Naevi. Nature 457 (7229), 599\u2013602 (2009).","journal-title":"Nature"},{"issue":"23","key":"3915_CR13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk, C. D. et al. Mutations in GNA11 in uveal melanoma. N Engl. J. Med. 363 (23), 2191\u20132199 (2010).","journal-title":"N Engl. J. Med."},{"issue":"5","key":"3915_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ijc.28436","volume":"134","author":"FC Bidard","year":"2014","unstructured":"Bidard, F. C. et al. Detection rate and prognostic value of Circulating tumor cells and Circulating tumor DNA in metastatic uveal melanoma. Int. J. Cancer. 134 (5), 1207\u20131213 (2014).","journal-title":"Int. J. Cancer"},{"key":"3915_CR15","doi-asserted-by":"crossref","unstructured":"Park, J. J. et al. Circulating tumor DNA reflects uveal melanoma responses to protein kinase C Inhibition. Cancers (Basel) 13 (7). (2021).","DOI":"10.3390\/cancers13071740"},{"issue":"4","key":"3915_CR16","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1097\/SLA.0000000000005822","volume":"278","author":"P Mariani","year":"2023","unstructured":"Mariani, P. et al. Circulating tumor DNA as a prognostic factor in patients with resectable hepatic metastases of uveal melanoma. Ann. Surg. 278 (4), e827\u2013e34 (2023).","journal-title":"Ann. Surg."},{"issue":"13","key":"3915_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1167\/iovs.64.13.35","volume":"64","author":"V Kim","year":"2023","unstructured":"Kim, V. et al. Release of Cell-Free tumor DNA in the plasma of uveal melanoma patients under radiotherapy. Invest. Ophthalmol. Vis. Sci. 64 (13), 35 (2023).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"3915_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/cam4.61","volume":"2","author":"CH Metz","year":"2013","unstructured":"Metz, C. H., Scheulen, M., Bornfeld, N., Lohmann, D. & Zeschnigk, M. Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma. Cancer Med. 2 (2), 208\u2013215 (2013).","journal-title":"Cancer Med."},{"issue":"17","key":"3915_CR19","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1002\/cam4.4153","volume":"10","author":"CHD Le Guin","year":"2021","unstructured":"Le Guin, C. H. D. et al. Early detection of metastatic uveal melanoma by the analysis of tumor-specific mutations in cell-free plasma DNA. Cancer Med. 10 (17), 5974\u20135982 (2021).","journal-title":"Cancer Med."},{"key":"3915_CR20","doi-asserted-by":"crossref","unstructured":"Im, D. H. et al. Potential of aqueous humor as a liquid biopsy for uveal melanoma. Int. J. Mol. Sci. 23(11). (2022).","DOI":"10.3390\/ijms23116226"},{"key":"3915_CR21","unstructured":"Pike, S. B. et al. Multicentre analysis of nucleic acid quantification using aqueous humour liquid biopsy in uveal melanoma: implications for clinical testing. Can. J. Ophthalmol. (2023)."},{"key":"3915_CR22","unstructured":"Sambrook, J., Fritsch, T. & Maniatis, T. Molecura Cloning (2.ed) (Cold Spring Harbor Laboratory Press, 1989)."},{"key":"3915_CR23","doi-asserted-by":"crossref","unstructured":"Le Guin, C. H. D. et al. GNAQ Q209R Mutations Are Highly Specific for Circumscribed Choroidal Hemangioma. Cancers (Basel). 11(7). (2019).","DOI":"10.3390\/cancers11071031"},{"key":"3915_CR24","first-page":"33","volume":"10","author":"F Molder","year":"2021","unstructured":"Molder, F. et al. Sustainable Data Anal. Snakemake F1000Res ;10 33. (2021).","journal-title":"Sustainable Data Anal. Snakemake F1000Res"},{"key":"3915_CR25","doi-asserted-by":"crossref","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011","DOI":"10.14806\/ej.17.1.200"},{"key":"3915_CR26","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv [Internet].  1303.3997v2. (2013). Available from: https:\/\/arxiv.org\/abs\/1303.3997"},{"issue":"6","key":"3915_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/bjc.2012.54","volume":"106","author":"S Thomas","year":"2012","unstructured":"Thomas, S. et al. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study. Br. J. Cancer. 106 (6), 1171\u20131176 (2012).","journal-title":"Br. J. Cancer"},{"issue":"3","key":"3915_CR28","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1167\/iovs.02-0159","volume":"44","author":"AG Scholes","year":"2003","unstructured":"Scholes, A. G. et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest. Ophthalmol. Vis. Sci. 44 (3), 1008\u20131011 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"3915_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s12253-017-0371-7","volume":"25","author":"B Schneider","year":"2019","unstructured":"Schneider, B. et al. Frequent and yet unreported GNAQ and GNA11 mutations are found in uveal melanomas. Pathol. Oncol. Res. 25 (4), 1319\u20131325 (2019).","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"3915_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/pcmedi\/pbz021","volume":"2","author":"ED Zhang","year":"2019","unstructured":"Zhang, E. D. et al. Mutation spectrum in GNAQ and GNA11 in Chinese uveal melanoma. Precis Clin. Med. 2 (4), 213\u2013220 (2019).","journal-title":"Precis Clin. Med."},{"issue":"5","key":"3915_CR31","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144 (5), 646\u2013674 (2011).","journal-title":"Cell"},{"issue":"5","key":"3915_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1091\/mbc.E20-04-0241","volume":"32","author":"MD Onken","year":"2021","unstructured":"Onken, M. D., Blumer, K. J. & Cooper, J. A. Uveal melanoma cells use ameboid and mesenchymal mechanisms of cell motility crossing the endothelium. Mol. Biol. Cell. 32 (5), 413\u2013421 (2021).","journal-title":"Mol. Biol. Cell."},{"issue":"12","key":"3915_CR33","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/eye.2009.235","volume":"23","author":"B Damato","year":"2009","unstructured":"Damato, B. & Coupland, S. E. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond). 23 (12), 2152\u20132160 (2009). quiz 61\u2009\u2013\u20092.","journal-title":"Eye (Lond)"},{"issue":"3","key":"3915_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.61.3.31","volume":"61","author":"M Dogrusoz","year":"2020","unstructured":"Dogrusoz, M. et al. Prognostic factors five years after enucleation for uveal melanoma. Invest. Ophthalmol. Vis. Sci. 61 (3), 31 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03915-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T09:14:29Z","timestamp":1748942069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03915-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03915-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and ethical approvals have been granted by the ethics committee of the University Duisburg Essen (22-10524-BO). Written informed consent to participate in this study was given by all 96 patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"19406"}}